The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
POLO: A randomized phase III trial of olaparib tablets in patients with metastatic pancreatic cancer (mPC) and a germline BRCA1/2mutation (gBRCAm) who have not progressed following first-line chemotherapy.
 
Hedy Lee Kindler
Consulting or Advisory Role - AstraZeneca/MedImmune; Celgene; Genentech/Roche; Gilead Sciences; GlaxoSmithKline; Seagen; Verastem
Research Funding - AB Science (Inst); Aduro Biotech (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Verastem (Inst)
 
Gershon Y. Locker
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Helen Mann
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Talia Golan
Consulting or Advisory Role - AstraZeneca